1. Home
  2. KLXE vs TIL Comparison

KLXE vs TIL Comparison

Compare KLXE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$1.71

Market Cap

35.8M

Sector

Energy

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$11.48

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
TIL
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.8M
74.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KLXE
TIL
Price
$1.71
$11.48
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$100.67
AVG Volume (30 Days)
153.3K
58.7K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$645,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$10.69
52 Week High
$7.40
$42.79

Technical Indicators

Market Signals
Indicator
KLXE
TIL
Relative Strength Index (RSI) 50.60 42.30
Support Level $1.57 $10.96
Resistance Level $1.98 $11.63
Average True Range (ATR) 0.14 0.55
MACD -0.00 0.27
Stochastic Oscillator 36.14 58.80

Price Performance

Historical Comparison
KLXE
TIL

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: